Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression Post author: Post published:October 4, 2023 Post category:uncategorized Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2). You Might Also Like AI and synthetic patients could make early diagnosis of chronic fatigue syndrome more feasible November 21, 2023 SP-101 gene therapy shows promise for cystic fibrosis treatment September 9, 2024 Study identifies rare diseases linked to increased COVID-19 mortality risks January 30, 2025
AI and synthetic patients could make early diagnosis of chronic fatigue syndrome more feasible November 21, 2023